Rheumatology Flashcards
Best way to distinguish primary and secondary raynauds
Nailfold Capilloroscopy - normal in primary raynauds
Why is febuxistat second line to allopurinol in gout prophylaxis?
Inhibits both reduced and oxidised forms of Xanthine Oxidase making it more potent but with higher risk of CVD and all-cause mortality
Treatment GCA
High dose steroids
Methotrexate
Tocilizumab (anti-IL6)
Anti-TNF inhibitors NOT recommended
Inclusion Body Myositis distribution
Asymmetrical Proximal and Distal weakness
- Quadracips
- Finger flexors - distinguishing factor
- Ankle dorsiflexion
- Cricopharyngeal involvement with dysphagia
Investigation findings inclusion body myositis
- Normal or mildly raised CK
- Biopsy;
1. Endomysial inflammation
2. Rimmed Vacuoles
3. Proteinaceous inclusions - EMG showing mixed myopathic and neuropathic process
Management of OA
Weight loss
Exercise
CBT
Proper footwear
NSAIDS
Duloxetine
Intra-articular steroids
Joint replacement
Renal transporters of uric acid
ABCG2 - excretion at proximal tubule (and gut)
URAT1 - reabsorption
Serology of drug-induced lupus
- ANA (without anti-dsDNA. Anti-smith, Anti-Ro)
- Anti-histone
ANCA Vasculitis types
- Granulomatosis with polyangitis (Wegners) - cANCA/PR3 - GN, Lung, Sinus, ENT
- Microscopic polyangitis - pANCA, MPO - GN and Lung
- Eosinophilic polyangitis Granulomatosis (Churg-Strauss) - pANCA - Asthma, Nasal polyps, atopy, GN
Anti-synthetase syndrome
- Anti-tRNA Ab - Anti-Jo and Anti-PL12
- Dermatomyositis
- Interstitial Lung Disease
- Raynauds
- Non-Erosive Arthritis
Diagnostic criteria for PMR
Must have;
Age > 50
Bilateral shoulder aching
Abnormal CRP or ESR
Plus > 4 of;
Morning stiffness > 45 minutes (2 points)
Hip pain/limited ROM
Absence of RF or Anti-CCP (2 points)
Absence of other joint involvement
USS findings of shoulder or hip bursitis/synovitis
Antibody associated with limited Scleroderma
Anti-Centromere
Antibodies associated with diffuse scleroderma
Anti-topoisomerase 1 (Scl-70)
Anti- RNA polymerase - increased risk of renal cell crisis and malignancy
Antibody associated with scleroderma renal crisis
Anti-RNA polymerase
Antibody associated with scleroderma interstitial lung disease
Anti-topoisomerase (Anti Scl-70)
Definition ‘Extensive’ scleroderma ILD
> 20% lung involvement on HRCT
FVC < 70%
DLCO < 55%
Treatment of Scleroderma renal crisis
ACE inhibitors
Due to RAAS blockade which leads to resolution of malignant HTN
Treatment of Scleroderma renal crisis
ACE inhibitors
Due to RAAS blockade which leads to resolution of malignant HTN
Rheumatoid arthritis diagnostic criteria
- Number of joints
- Seropositivity (RF +/- Anti-CCP)
- CRP or ESR
- Duration of symptoms > 6 weeks
Feltys syndrome
Neutropenia
Splenomegaly
Rheumatoid arthritis
Leg Ulcers
Imaging findings in RA
Symmetrical
Sparing of DIP
Joint space narrowing with Ankylosis
Erosions
Periarticular ostopenia
Soft-tissue swelling
Subluxation
Major cause of death in RA
Cardiovascular disease (associated with higher CRP levels at baseline)
Abatacept
CTLA receptor agonist which inactivates CD4 cells.
Can lead to normal CRP in patients despite infection or inflammation